Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?

Background: It is important to understand the implications of reduced bacillus Calmette-Guérin (BCG) treatment intensity, given global shortages and early termination of the NIMBUS trial. Objective: To assess the association of partial versus complete BCG induction with outcomes. Design, setting, an...

Description complète

Détails bibliographiques

Auteurs principaux:	Michael E. Rezaee, A. Aziz Ould Ismail, Chiamaka L. Okorie, John D. Seigne, Kristine E. Lynch, Florian R. Schroeck
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2021-04-01
Collection:	European Urology Open Science
Sujets:	Bladder cancer Bacillus Calmette-Guérin Immunotherapy Transurethral resection Outcomes
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2666168321000161
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!